Showing results (111-120 of 824) with videos related to

Sort By:
Pageof 83
Molecular Cancer Therapeutics|June 19, 2007
5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cellsTanyel Kiziltepe, Teru Hideshima, Laurence Catley, et al.
Cancer Drug Resistance (Alhambra, Calif.)|March 10, 2022
Overcoming drug resistance by targeting protein homeostasis in multiple myelomaMaria Moscvin, Matthew Ho, Giada Bianchi
Journal of Cancer Metastasis and Treatment|January 12, 2024
Dissecting molecular mechanisms of immune microenvironment dysfunction in multiple myeloma and precursor conditionsMaria Moscvin, Benjamin Evans, Giada Bianchi
Frontiers in Oncology|November 30, 2020
Exosomes in the Pathogenesis and Treatment of Multiple Myeloma in the Context of the Bone Marrow MicroenvironmentTianzeng Chen, Maria Moscvin, Giada Bianchi
Journal of Economic Dynamics & Control|December 12, 2022
The long-term impact of the COVID-19 unemployment shock on life expectancy and mortality ratesFrancesco Bianchi, Giada Bianchi, Dongho Song
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Neutralizing B-cell activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined immunodeficient human multiple myeloma modelPaola Neri, Shaji Kumar, Maria Teresa Fulciniti, et al.
Blood|December 14, 2002
Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arraysDharminder Chauhan, Guilan Li, Daniel Auclair, et al.
Blood|August 21, 2004
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myelomaNoopur Raje, Shaji Kumar, Teru Hideshima, et al.
Leukemia Research|January 17, 2002
Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridolIgor Semenov, Canan Akyuz, Vera Roginskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironmentToshiaki Hayashi, Teru Hideshima, Aaron N Nguyen, et al.
Pageof 83